当前位置:首页 > 股票大全 > 双成药业 002693 财务分析

双成药业财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

双成药业(002693)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入42,761,740.63235,929,899.37182,248,825.9139,013,360.1
营业总成本57,356,433.81278,156,880.41213,053,392.18150,367,222.37
营业利润-14,178,627.36-73,153,950.97-17,813,958.23-1,217,250.49
利润总额-14,190,653.53-72,967,935.71-17,409,927.61-810,017.66
净利润-14,190,653.53-71,976,341.83-17,435,104.7-835,194.75
其他综合收益-2,853.716,375.081,726.710,157.21
综合收益总额-14,193,507.24-71,969,966.75-17,433,378-825,037.54
双成药业(002693)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计131,101,295.59135,235,873.61203,023,149.88252,244,470.03
非流动资产合计667,355,536.99668,012,248.28658,440,660.66650,904,991.98
资产总计798,456,832.58803,248,121.89861,463,810.54903,149,462.01
流动负债合计129,242,548.99139,942,078.15273,428,376.16301,894,883.61
非流动负债合计165,529,940.86145,660,446.0111,178,092.6510,180,330.7
负债合计294,772,489.85285,602,524.16284,606,468.81312,075,214.31
归属于母公司股东权益合计462,972,614.34471,485,892.58525,277,410.41533,305,230.27
股东权益合计503,684,342.73517,645,597.73576,857,341.73591,074,247.7
负债和股东权益合计798,456,832.58803,248,121.89861,463,810.54903,149,462.01
双成药业(002693)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计46,288,023.21287,686,123.2216,678,598.23159,376,955.11
经营活动现金流出小计69,928,150.8276,046,661.73243,695,440.57179,080,487.07
经营活动产生的现金流量净额-23,640,127.5911,639,461.47-27,016,842.34-19,703,531.96
投资活动现金流入小计46,581,555.73365,131,543.15334,397,094.32264,433,468.54
投资活动现金流出小计33,124,566.8340,711,248.45279,940,627.48209,974,314.01
投资活动产生的现金流量净额13,456,988.9324,420,294.754,456,466.8454,459,154.53
筹资活动现金流入小计25,931,612.2430,364,737.7214,911,498.7510,497,374.62
筹资活动现金流出小计1,461,833.3369,831,194.5445,419,980.568,715,001.39
筹资活动产生的现金流量净额24,469,778.91-39,466,456.82-30,508,481.811,782,373.23
汇率变动对现金及现金等价物的影响10,483.7-2,921.74-15,821.1122,795.92
现金及现金等价物净增加额14,297,123.95-3,409,622.39-3,084,678.4236,560,791.72
期末现金及现金等价物余额17,684,279.513,387,155.563,712,099.5343,357,569.67
双成药业002693相关数据
今日股市大盘指数